Author

M. Elgrably-Weiss

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:chromatin & epigenetic regulation· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:benchmarking· 1 Research Focus:cell signaling & trafficking· 1 Approach:comparative / phylogenetic analysis· 1

Frequent Co-Authors

R. Wiener· 3 shared S. Altuvia· 3 shared A. Rouvinski· 2 shared D. Padawer· 2 shared E. Cohen-Kfir· 2 shared L. Baraz· 2 shared M. Billan· 2 shared M. Kumar· 2 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

R. Wiener

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Binding of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody-mediated complement deposition

J. Fahoum, M. Billan, J. K. Varga, D. Padawer, M. Elgrably-Weiss, P. Basu, M. Stolovich-Rain, L. Baraz, S. Kumari, E. Oiknine-Dijan, M. Kumar, E. Cohen-Kfir, O. Zelig, G. Mayer, M. N. Isupov, , A. Rouvinski

This study shows that SARS-CoV-2 nucleocapsid protein binds to uninfected cells, triggering antibody-mediated complement activation in COVID-19 patients.

bioRxiv · Mar 17, 2024 · PreprintImmunology

Balanced cell division is secured by two different regulatory sites in OxyS RNA

M. Elgrably-Weiss, F. Hussain, J. Georg, B. Shraiteh, S. Altuvia

This study identifies that OxyS RNA inhibits both cell division and cell elongation in E. coli, with mepS being a conserved target across 64% of organisms.

bioRxiv · Oct 19, 2023Microbiology

Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces robust neutralizing salivary IgA

M. Stolovich-Rain, S. Kumari, A. Friedman, S. Kirillov, Y. Socol, M. Billan, R. Ranjan Pal, P. Golding, E. Oiknine-Djian, S. Sirhan, M. Bejerano Sagie, E. Cohen-Kfir, M. Elgrably-Weiss, B. Zhou, M. Ravins, , A. Rouvinski

This study shows that the BNT162b2 mRNA vaccine induces temporary salivary IgA with strong neutralizing activity against SARS-CoV-2.

Frontiers in Immunology · Jan 30, 2023Peer-reviewedMicrobiology

RNA binding of Hfq monomers promotes RelA-mediated hexamerization in a limiting Hfq environment

P. Basu, M. Elgrably-Weiss, F. Hassouna, M. Kumar, R. Wiener, S. Altuvia

This study shows that RelA-mediated Hfq hexamerization requires RNA binding to Hfq monomers, challenging the idea that only hexamers can bind RNA.

bioRxiv · Aug 11, 2020Microbiology